Seminars in Hematology
Volume 45, Issue 4 , Pages 250-254 , October 2008

Unexplained Anemia in the Elderly

References 

  1. Guralnik JM, Eisenstaedt RS, Ferrucci L, Klein HG, Woodman RC. Prevalence of anemia in persons 65 years and older in the United States: Evidence for a high rate of unexplained anemia. Blood. 2004;104:2263–2268
  2. Ania BJ, Suman VJ, Fairbanks VF, Rademacher DM, Melton LJ. Incidence of anemia in older people: An epidemiologic study in a well defined population. J Am Geriatr Soc. 1997;45:825–831
  3. Nissenson AR, Goodnough LT, Dubois RW. Anemia: Not just an innocent bystander?. Arch Intern Med. 2003;163:1400–1404
  4. Penninx BW, Guralnik JM, Onder G, Ferrucci L, Wallace RB, Pahor M. Anemia and decline in physical performance among older persons. Am J Med. 2003;115:104–110
  5. Penninx BW, Pahor M, Cesari M, Corsi AM, Woodman RC, Bandinelli S, et al. Anemia is associated with disability and decreased physical performance and muscle strength in the elderly. J Am Geriatr Soc. 2004;52:719–724
  6. Penninx BW, Pluijm SM, Lips P, Woodman R, Miedema K, Guralnik JM, et al. Late-life anemia is associated with increased risk of recurrent falls. J Am Geriatr Soc. 2005;53:2106–2111
  7. Chaves PH, Ashar B, Guralnik JM, Fried LP. Looking at the relationship between hemoglobin concentration and prevalent mobility difficulty in older women (Should the criteria currently used to define anemia in older people be reevaluated?). J Am Geriatr Soc. 2002;50:1257–1264
  8. Izaks GJ, Westendorp RG, Knook DL. The definition of anemia in older persons. JAMA. 1999;281:1714–1717
  9. Ezekowitz JA, McAlister FA, Armstrong PW. Anemia is common in heart failure and is associated with poor outcomes: Insights from a cohort of 12 065 patients with new-onset heart failure. Circulation. 2003;107:223–225
  10. Chaves PH, Xue QL, Guralnik JM, Ferrucci L, Volpato S, Fried LP. What constitutes normal hemoglobin concentration in community-dwelling disabled older women?. J Am Geriatr Soc. 2004;52:1811–1816
  11. Wu WC, Schifftner TL, Henderson WG, Eaton CB, Poses RM, Uttley G, et al. Preoperative hematocrit levels and postoperative outcomes in older patients undergoing noncardiac surgery. JAMA. 2007;297:2481–2488
  12. Baylis C, Schmidt R. The aging glomerulus. Semin Nephrol. 1996;16:265–276
  13. Shumway JT, Gambert SR. Diabetic nephropathy-pathophysiology and management. Int Urol Nephrol. 2002;34:257–264
  14. Clark B. Biology of renal aging in humans. Adv Renal Replace Ther. 2000;7:11–21
  15. Spivak JL. Serum immunoreactive erythropoietin in health and disease. J Perinat Med. 1995;23:13–17
  16. Ershler WB, Sheng S, McKelvey J, Artz AS, Denduluri N, Tecson J, et al. Serum erythropoietin and aging: a longitudinal analysis. J Am Geriatr Soc. 2005;53:1360–1365
  17. Artz AS, Fergusson D, Drinka PJ, Gerald M, Bidenbender R, Lechich AS, et al. Mechanisms of unexplained anemia in the nursing home. J Am Geriatr Soc. 2004;52:423–427
  18. Kario K, Matsuo T, Kodama K, Nakao K, Asada R. Reduced erythropoietin secretion in senile anemia. Am J Hematol. 1992;41:252–257
  19. Kario K, Matsuo T, Nakao K. Serum erythropoietin levels in the elderly. Gerontology. 1991;37:345–348
  20. Powers JS, Krantz SB, Collins JC, Meurer K, Failinger A, Bucholz T, et al. Erythropoietin response to anemia as a function of age. J Am Geriatr Soc. 1991;39:30–32
  21. Artz AS, Fergusson D, Drinka PJ, Gravenstein S, Lehich A, Silverstone F, et al. Prevalence of anemia in skilled-nursing home residents. Arch Gerontol Geriatr. 2004;39:201–206
  22. Landi F, Russo A, Danese P, Liperoti R, Barillaro C, Bernabei R, et al. Anemia status, hemoglobin concentration, and mortality in nursing home older residents. J Am Med Dir Assoc. 2007;8:322–327
  23. Robinson B, Artz AS, Culleton B, Critchlow C, Sciarra A, Audhya P. Prevalence of anemia in the nursing home: Contribution of chronic kidney disease. J Am Geriatr Soc. 2007;55:1566–1570
  24. Dumble M, Moore L, Chambers SM, Geiger H, Van Zant G, Goodell MA, et al. The impact of altered p53 dosage on hematopoietic stem cell dynamics during aging. Blood. 2007;109:1736–1742
  25. Rossi DJ, Bryder D, Weissman IL. Hematopoietic stem cell aging: mechanism and consequence. Exp Gerontol. 2007;42:385–390
  26. Rossi DJ, Jamieson CH, Weissman IL. Stems cells and the pathways to aging and cancer. Cell. 2008;132:681–696
  27. Rossi DJ, Seita J, Czechowicz A, Bhattacharya D, Bryder D, Weissman IL. Hematopoietic stem cell quiescence attenuates DNA damage response and permits DNA damage accumulation during aging. Cell Cycle. 2007;6:2371–2376
  28. Shahidi NT: Androgens and erythropoiesis. N Engl J Med 289:72-80, 1073
  29. Nissen C, Gratwohl A, Speck B. Management of aplastic anemia. Eur J Haematol. 1991;46:193–197
  30. Schafer PH, Gandhi AK, Loveland MA, Chen RS, Man HW, Schnetkamp PP, et al. Enhancement of cytokine production and AP-1 transcriptional activity in T cells by thalidomide-related immunomodulatory drugs. J Pharmacol Exp Ther. 2003;305:1222–1232
  31. Schubert M, Jockenhovel F. Late-onset hypogonadism in the aging male (LOH): Definition, diagnostic and clinical aspects. J Endocrinol Invest. 2005;28(suppl 3):23–27
  32. Voegeli TA, Kurtz A, Grimm MO, Effert P, Eckardt KU. Anemia under androgen deprivation: Influence of flutamide, cyproteroneacetate and orchiectomy on the erythropoietin system. Horm Metab Res. 2005;37:3789–3793
  33. Asbell SO, Leon SA, Tester WJ, Brereton HD, Ago CT, Rotman M. Development of anemia and recovery in prostate cancer patients treated with combined androgen blockade and radiotherapy. Prostate. 1996;29:243–248
  34. Ferrucci L, Maggio M, Bandinelli S, Basaria S, Lauretani F, Ble A, et al. Low testosterone levels and the risk of anemia in older men and women. Arch Intern Med. 2006;166:1380–1388
  35. Ershler WB. Biological interactions of aging and anemia: A focus on cytokines. J Am Geriatr Soc. 2003;51:S18–S21
  36. Moldawer LL, Marano MA, Wei H, Fong Y, Silen ML, Kuo G, et al. Cachectin/tumor necrosis factor-alpha alters red blood cell kinetics and induces anemia in vivo. FASEB J. 1989;3:1637–1643
  37. Zamai L, Secchiero P, Pierpaoli S, Bassini A, Papa S, Alnemri ES. TNF-related apoptosis-inducing ligand (TRAIL) as a negative regulator of normal human erythropoiesis. Blood. 2000;95:3716–3724
  38. Sears DA. Anemia of chronic disease. Med Clin North Am. 1992;76:567–579
  39. Weiss G. Pathogenesis and treatment of anaemia of chronic disease. Blood Rev. 2002;16:87–96
  40. Andrews NC. Anemia of inflammation: The cytokine-hepcidin link. J Clin Invest. 2004;113:1251–1253
  41. Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood. 2003;102:783–788
  42. Ganz T. Hepcidin—A peptide hormone at the interface of innate immunity and iron metabolism. Curr Top Microbiol Immunol. 2006;306:183–198
  43. Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest. 2004;113:1271–1276
  44. Ferrucci L, Corsi A, Lauretani F, Bandinelli S, Bartali B, Taub DD, et al. The origins of age-related proinflammatory state. Blood. 2005;105:2294–2299
  45. Hak AE, Pols HA, Stehouwer CD, Meijer J, Kiliaan AJ, Hofman A, et al. Markers of inflammation and cellular adhesion molecules in relation to insulin resistance in nondiabetic elderly: the Rotterdam study. J Clin Endocrinol Metab. 2001;86:4398–4405
  46. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA. 1992;282:2131–2135
  47. Visser M, Pahor M, Taaffe DR, Goodpaster BH, Simonsick EM, Newman AB, et al. Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: The Health ABC Study. J Gerontol A Biol Sci Med Sci. 2002;57:M326–M332
  48. Ray P, Ghosh SK, Zhang DH, Ray A. Repression of interleukin-6 gene expression by 17 beta-estradiol: Inhibition of the DNA-binding activity of the transcription factors NF-IL6 and NF-kappa B by the estrogen receptor. FEBS Lett. 1997;409:79–85
  49. Sun WH, Keller ET, Stebler BS, Ershler WB. Estrogen inhibits phorbol ester-induced I kappa B alpha transcription and protein degradation. Biochem Biophys Res Commun. 1998;244:691–695
  50. Keller ET, Chang C, Ershler WB. Inhibition of NFkappa B activity through maintenance of IkappaBalpha levels contributes to dihydrotestosterone-mediated repression of the interleukin-6 promoter. J Biol Chem. 1996;271:26267–26275
  51. Cooper AC, Mikhail A, Lethbridge MW, Kemeny DM, Macdougall IC. Increased expression of erythropoiesis inhibiting cytokines (IFN-gamma, TNF-alpha, IL-10, and IL-13) by T cells in patients exhibiting a poor response to erythropoietin therapy. J Am Soc Nephrol. 2003;14:1776–1784
  52. Macdougall IC, Cooper AC. Erythropoietin resistance: The role of inflammation and pro-inflammatory cytokines. Nephrol Dial Transplant. 2002;17(suppl):39–43
  53. Bennett JM, Kouides PA, Forman SJ. The myelodysplastic syndromes: Morphology, risk assessment, and clinical management (2002). Int J Hematol. 2002;76(suppl):228–238
  54. Steensma DP, Bennett JM. The myelodysplastic syndromes: Diagnosis and treatment. Mayo Clin Proc. 2006;81:104–130
  55. Joosten E, Pelemans W, Hiele M, Noyen J, Verhaeghe R, Boogaerts MA. Prevalence and causes of anaemia in a geriatric hospitalized population. Gerontology. 1992;38:111–117
  56. Agnihotri P, Telfer M, Butt Z, Jella A, Cella D, Kozma CM, et al. Chronic anemia and fatigue in elderly patients: results of a randomized, double-blind, placebo-controlled, crossover exploratory study with epoetin alfa. J Am Geriatr Soc. 2007;55:1557–1565
  57. Ble A, Fink JC, Woodman RC, Klausner MA, Windham BG, Guralnik JM. Renal function, erythropoietin, and anemia of older persons: The InCHIANTI study. Arch Intern Med. 2005;165:2222–2227

 Supported by the Intramural Research Program, National Institute on Aging, National Institutes of Health.

PII: S0037-1963(08)00105-4

doi: 10.1053/j.seminhematol.2008.06.003

Seminars in Hematology
Volume 45, Issue 4 , Pages 250-254 , October 2008

Article Tools